Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-01 TAHL CINDY General Counsel and Secretary Sale −25,000 $22.96 $574K 189,151
2022-06-01 TAHL CINDY General Counsel and Secretary Option exercise · Stock Option (Right to Buy) −25,000 54,210
2022-04-22 Wolchko J Scott President and CEO Option exercise +10,000 $2.70 $27K 441,546
2022-04-22 Wolchko J Scott President and CEO Sale −9,162 $34.54 $316K 432,384
2022-04-22 Wolchko J Scott President and CEO Sale −838 $35.15 $29K 431,546
2022-04-22 Wolchko J Scott President and CEO Option exercise · Stock Option (Right to Buy) −10,000 $2.70 $27K 36,246
2022-04-21 Wolchko J Scott President and CEO Option exercise +30,000 $2.70 $81K 461,546
2022-04-21 Wolchko J Scott President and CEO Sale −22,715 $34.57 $785K 438,831
2022-04-21 Wolchko J Scott President and CEO Sale −4,062 $35.73 $145K 434,769
2022-04-21 Wolchko J Scott President and CEO Sale −2,220 $36.70 $81K 432,549
2022-04-21 Wolchko J Scott President and CEO Sale −1,003 $37.90 $38K 431,546
2022-04-21 Wolchko J Scott President and CEO Option exercise · Stock Option (Right to Buy) −30,000 $2.70 $81K 46,246
2022-04-19 Chu Yu-Waye Chief Medical Officer Sale −4,062 $35.37 $144K 151,033
2022-04-01 TAHL CINDY General Counsel and Secretary Option exercise +19,433 $4.84 $94K 208,584
2022-04-01 TAHL CINDY General Counsel and Secretary Option exercise +5,567 $6.55 $36K 214,151
2022-04-01 TAHL CINDY General Counsel and Secretary Sale −25,000 $38.85 $971K 189,151
2022-04-01 TAHL CINDY General Counsel and Secretary Option exercise · Stock Option (Right to Buy) −19,433 8,195
2022-04-01 TAHL CINDY General Counsel and Secretary Option exercise · Stock Option (Right to Buy) −5,567 79,210
2022-03-14 Valamehr Bahram Chief R&D Officer Option exercise +25,000 $2.73 $68K 204,834
2022-03-14 Valamehr Bahram Chief R&D Officer Sale −16,678 $30.36 $506K 188,156

Page 11 of 26 · 503 trades